|
Market Closed -
Nasdaq
08:00:00 21/11/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 1.580 USD | +1.66% |
|
-1.25% | -94.45% |
Company Valuation: Scinai Immunotherapeutics Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 32.38 | 43.42 | 10.32 | 2.591 | 2.853 | 2.47 |
| Change | - | 34.08% | -76.24% | -74.88% | 10.12% | -13.44% |
| Enterprise Value (EV) 1 | 90.12 | 59.12 | 17.78 | 18.28 | 2.975 | 3.076 |
| Change | - | -34.4% | -69.92% | 2.8% | -83.73% | 3.38% |
| P/E | - | - | - | - | - | -0.2x |
| PBR | - | - | - | -0.61x | 0.66x | 1x |
| PEG | - | - | - | - | - | - |
| Capitalization / Revenue | - | - | - | - | 4,336,096x | 1,883,833x |
| EV / Revenue | - | - | - | - | - | - |
| EV / EBITDA | 10.2x | -1.77x | -1.69x | -1.99x | -0.43x | -0.5x |
| EV / EBIT | 12.3x | -1.7x | -1.61x | -1.88x | -0.34x | -0.41x |
| EV / FCF | -14.9x | -4.18x | -2.07x | -3.1x | -0.78x | -0.92x |
| FCF Yield | -6.7% | -23.9% | -48.2% | -32.3% | -128% | -108% |
| Dividend per Share 3 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 3 | - | - | - | - | - | -142.3 |
| Distribution rate | - | - | - | - | - | - |
| Net sales | - | - | - | - | 0.658 | 1.311 |
| EBITDA 1 | 8.84 | -33.31 | -10.5 | -9.192 | -6.989 | -6.121 |
| EBIT 1 | 7.334 | -34.83 | -11.06 | -9.706 | -8.638 | -7.542 |
| Net income 1 | -4.455 | -39.98 | -5.796 | -6.5 | 4.796 | -8.307 |
| Net Debt 1 | 57.74 | 15.7 | 7.467 | 15.69 | 0.122 | 0.606 |
| Reference price 3 | 11,240.000 | 9,400.000 | 1,184.000 | 238.160 | 133.800 | 28.484 |
| Nbr of stocks (in thousands) | 2.88 | 4.62 | 8.71 | 10.9 | 21.3 | 86.7 |
| Announcement Date | 13/5/21 | 28/3/22 | 17/4/23 | 15/5/24 | 7/5/25 | 1/4/26 |
1USD in Million2ILS in Million3USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 535K | ||
| 16.7x | 6.32x | 12.11x | 1.79% | 63.66B | ||
| 31.66x | 8.45x | 27.93x | 0.07% | 58.56B | ||
| 37.7x | 6.72x | 20.09x | 0.86% | 54.19B | ||
| 40.47x | 5.8x | 27.69x | -.--% | 44.66B | ||
| 32.09x | 3.11x | 13.42x | -.--% | 40.51B | ||
| 36.32x | 8.88x | 23.19x | 0.36% | 36.27B | ||
| -19.54x | 51.81x | -20.9x | -.--% | 34.87B | ||
| 41.15x | 7.94x | 26.62x | -.--% | 32.26B | ||
| -87.55x | 16.38x | -94.1x | -.--% | 31.01B | ||
| Average | 14.33x | 12.82x | 4.00x | 0.34% | 40B | |
| Weighted average by Cap. | 18.48x | 11.46x | 8.41x | 0.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- SCNI Stock
- Valuation Scinai Immunotherapeutics Ltd.
Select your edition
All financial news and data tailored to specific country editions
















